We are pleased to announce an MoU with JSS Medical College and Academy of Higher Education and Research, Mysuru to work together in the areas of hemoglobinopathies and rare diseases. The aim is to work on collaborative projects to develop affordable and efficient diagnostics, therapeutics, and treatment options.
Related Posts
An Uphill Battle
Dr. Vasanth Thamodaran, Senior Scientist at TIGS was featured in an article... read more
Impact of Covid ‘is down but not out’, do not be careless: Health experts
In an exclusive interview to ANI, the Director of Tata Institute for... read more
On the new recent surge in Covid 19 cases and JN.1 variant
The Tata Institute for Genetics and Society (TIGS) has been conducting sewage... read more
India must scale up wastewater analysis for health surveillance
In this latest opinion piece by Dr. Farah Ishtiaq, Principal Scientist, TIGS... read more
TIGS Annual Report 2022
Annual Report 2022 Click on the above image or here to view TIGS... read more
“We want to make mRNA technology affordable to our society” – Dr. Rakesh Mishra | Interview to BioSpectrum
How can genetics and genomics research create real societal impact? In an exclusive... read more
Interview with Dr.Rakesh Mishra on IndiaScience TV
How dangerous is the new XE variant of Covid-19? Is the Covid... read more
Discarded storage containers may be aggravating Bengaluru dengue outbreaks
In this latest piece by Dr. Farah Ishtiaq, Principal Scientist, TIGS in... read more
Genetics has revolutionised patient selection for clinical trials
Vaccines are not necessarily the best or only therapy against a viral... read more
Sustainability Ambassadors Global Exchange Program Organised by Echo Network along with TIGS and others
TIGS along with Echo network and Nordic Centre in India host the... read more

